M118 needs to complete one or more phase-2b studies before embarking on phase-3, so what we’re talking about is the cumulative development cost for phase-2b and phase-3.
Do you have any ballpark guesstimate on how much such remaining trials would cost? $100 million? $200 million? Much more?